相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Selective cytotoxicity of A6 peptide against ZAP-70 expressing CLL B-cells
Hsien Lai et al.
CANCER RESEARCH (2014)
Involvement of Urokinase-Type Plasminogen Activator System in Cancer: An Overview
Ahmed H. Mekkawy et al.
MEDICINAL RESEARCH REVIEWS (2014)
Targeting chronic lymphocytic leukemia cells with a humanized monoclonal antibody specific for CD44
Suping Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
ON 01910.Na Is Selectively Cytotoxic for Chronic Lymphocytic Leukemia Cells through a Dual Mechanism of Action Involving PI3K/AKT Inhibition and Induction of Oxidative Stress
Colby M. Chapman et al.
CLINICAL CANCER RESEARCH (2012)
A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: A Gynecologic Oncology Group study
Michael A. Gold et al.
GYNECOLOGIC ONCOLOGY (2012)
Role of Hyaluronan-Mediated CD44 Signaling in Head and Neck Squamous Cell Carcinoma Progression and Chemoresistance
Steven J. Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Understanding the Dual Nature of CD44 in Breast Cancer Progression
Jeanne M. V. Louderbough et al.
MOLECULAR CANCER RESEARCH (2011)
A6 Peptide Activates CD44 Adhesive Activity, Induces FAK and MEK Phosphorylation, and Inhibits the Migration and Metastasis of CD44-Expressing Cells
Randolph S. Piotrowicz et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1
Yair Herishanu et al.
LEUKEMIA & LYMPHOMA (2011)
Rethinking the metastatic cascade as a therapeutic target
Lida A. Mina et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Breast Cancer Dormancy Can Be Maintained by Small Numbers of Micrometastases
Lisa Willis et al.
CANCER RESEARCH (2010)
CD44 Attenuates Activation of the Hippo Signaling Pathway and Is a Prime Therapeutic Target for Glioblastoma
Yin Xu et al.
CANCER RESEARCH (2010)
Does tumour dormancy offer a therapeutic target?
Paul E. Goss et al.
NATURE REVIEWS CANCER (2010)
A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis
Martina Tremmel et al.
BLOOD (2009)
CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts
E. Marangoni et al.
BRITISH JOURNAL OF CANCER (2009)
Rheostatic signaling by CD44 and hyaluronan
Ellen Pure et al.
CELLULAR SIGNALLING (2009)
Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities
Bryan P. Toole
CLINICAL CANCER RESEARCH (2009)
The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Salvatore Ulisse et al.
CURRENT CANCER DRUG TARGETS (2009)
Inhibition of migration and invasion of carcinoma cells by urokinase-derived antagonists of αvβ5 integrin activation
Immacolata Vocca et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Hyaluronan-mediated CD44 Interaction with p300 and SIRT1 Regulates β-Catenin Signaling and NFκB-specific Transcription Activity Leading to MDR1 and Bcl-xL Gene Expression and Chemoresistance in Breast Tumor Cells
Lilly Y. W. Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Hyaluronan-CD44 Interaction with Protein Kinase Cε Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells
Lilly Y. W. Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
EMT: When epithelial cells decide to become mesenchymal-like cells
Raghu Kalluri
JOURNAL OF CLINICAL INVESTIGATION (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Hyaluronan, CD44 and Emmprin: Partners in cancer cell chemoresistance
Bryan P. Toole et al.
DRUG RESISTANCE UPDATES (2008)
A peptide inhibitor of the urokinase/urokinase receptor system inhibits alteration of the blood-retinal barrier in diabetes
Deepti Navaratna et al.
FASEB JOURNAL (2008)
A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous Å6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer
Sharad A. Ghamande et al.
GYNECOLOGIC ONCOLOGY (2008)
Differential Activation of ERK and Rac Mediates the Proliferative and Anti-proliferative Effects of Hyaluronan and CD44
Devashish Kothapalli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells
Lilly Y. W. Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
CD44-epidermal growth factor receptor interaction mediates hyaluronic acid-promoted cell motility by activating protein kinase C signaling involving Akt, Rac1, Phox, reactive oxygen species, focal adhesion kinase, and MMP-2
Youngmi Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody
Itshak Golan et al.
JOURNAL OF AUTOIMMUNITY (2007)
Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression
Elizabeth S. Colombo et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and αvβ5 integrin
Paola Franco et al.
JOURNAL OF CELL SCIENCE (2006)
Involvement of endothelial CD44 during in vivo angiogenesis
Gaoyuan Cao et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Effect of a novel octapeptide urokinase fragment, A°6, on experimental choroidal neovascularization in the monkey
Hyoung J. Koh et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Å6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer:: A phase I trial
A Berkenblit et al.
GYNECOLOGIC ONCOLOGY (2005)
Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44
P Teriete et al.
MOLECULAR CELL (2004)
Inhibition of choroidal neovascularization in rats by the urokinase-derived peptide A6
HJ Koh et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Circulating tumor cells in patients with breast cancer dormancy
SD Meng et al.
CLINICAL CANCER RESEARCH (2004)
Inhibition of choroidal neovascularization by a peptide inhibitor of the urokinase plasminogen activator and receptor system in a mouse model
A Das et al.
ARCHIVES OF OPHTHALMOLOGY (2004)
The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer
MJ Duffy et al.
CLINICAL BIOCHEMISTRY (2004)
Hyaluronan recognition mode of CD44 revealed by cross-saturation and chemical shift perturbation experiments
M Takeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy
N Sidenius et al.
CANCER AND METASTASIS REVIEWS (2003)
The Urokinase/Urokinase receptor system in retinal neovascularization:: Inhibition by Å6 suggests a new therapeutic target
PG McGuire et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
A urokinase-derived peptide (Å6) increases survival of mice bearing orthotopically grown prostate cancer and reduces lymph node metastasis
DD Boyd et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Epithelial-mesenchymal transitions in development and pathologies
JP Thiery
CURRENT OPINION IN CELL BIOLOGY (2003)
CD44: From adhesion molecules to signalling regulators
H Ponta et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Hyaluronan binding properties of a CD44 chimera containing the link module of TSG-6
J Lesley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Inhibition of receptor-dependent urokinase signaling by specific Ser to Glu substitutions
MV Carriero et al.
BIOLOGICAL CHEMISTRY (2002)
Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis
RC Savani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin
K Mishima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy
A Cantón et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2000)
A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo
YJ Guo et al.
FASEB JOURNAL (2000)
分享论文
